HIGH

Glenmark Azelaic Acid Gel Recall Affects 13,824 Tubes Sold Nationwide in 2025

Glenmark Pharmaceuticals Inc. USA recalls 13,824 tubes of azelaic acid gel 15% after CGMP deviations prompted gritty texture complaints. The recall covers nationwide distribution in the United States. Consumers should stop using the product and contact Glenmark for guidance.

Quick Facts at a Glance

Recall Date
September 17, 2025
Hazard Level
HIGH
Brands
Glenmark Pharmaceuticals, AZELAIC ACID
Category
Health & Personal Care
Sold At
Multiple Retailers, Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, PETS

Hazard Information

CGMP Deviations: Market complaints received for gritty texture (grainy)

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Glenmark Pharmaceuticals Inc., USA or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Azelaic acid gel is a topical treatment used for various dermatologic conditions. It is Rx-only in the U.S. and distributed nationwide.

Why This Is Dangerous

Gritty texture indicates CGMP deviations possibly affecting product quality and safety of application.

Industry Context

This recall is not part of a broader industry pattern, based on provided notice.

Real-World Impact

Consumers may experience quality concerns or irritation due to altered texture; no injuries reported in the notice.

Practical Guidance

How to identify if yours is affected

  1. Check NDC 68462-626-52 on the packaging.
  2. Check Batch #19252524 and Exp May 2027.
  3. Confirm product is a 50 g tube labeled Rx only.

Where to find product info

Recall letter from Glenmark and FDA enforcement page D-0662-2025.

What timeline to expect

Refunds/replacements typically processed within 4-8 weeks after submission.

If the manufacturer is unresponsive

  • Document your correspondence
  • Escalate to FDA consumer complaint if needed

How to prevent similar issues

  • Verify CGMP compliance updates from manufacturers
  • Ask for batch-specific documentation when purchasing Rx drugs
  • Monitor recalls on FDA and company websites

Documentation advice

Keep recall letter, batch numbers, expiration date, and receipts as records.

Product Details

Brand: Glenmark Pharmaceuticals. Product: Azelaic Acid Gel, 15%, 50 g. NDC: 68462-626-52. Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430. Batch: 19252524. Expiration: May 2027. Sold as Rx only. Quantity: 13,824 tubes. Distribution: Nationwide in the United States.

Reported Incidents

No injuries or incidents are detailed in the recall notice.

Key Facts

  • 13,824 tubes recalled
  • Azelaic Acid Gel 15% 50 g
  • NDC 68462-626-52
  • Batch #19252524
  • Exp May 2027
  • Rx only

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTPETS
Injury Types
OTHER

Product Details

Model Numbers
Batch # 19252524
Exp Date: May 2027
UPC Codes
68462-626
68462-626-52
Affected States
ALL
Report Date
October 1, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more